Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 9

1.

Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy.

Mather SJ, McKenzie AJ, Sosabowski JK, Morris TM, Ellison D, Watson SA.

J Nucl Med. 2007 Apr;48(4):615-22.

2.

CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

Nock BA, Maina T, Béhé M, Nikolopoulou A, Gotthardt M, Schmitt JS, Behr TM, Mäcke HR.

J Nucl Med. 2005 Oct;46(10):1727-36.

3.

Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats.

Wang H, Wong PT, Spiess J, Zhu YZ.

Neurosci Biobehav Rev. 2005;29(8):1361-73. Epub 2005 Aug 24. Review.

PMID:
16120463
4.

99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.

von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.

Bioconjug Chem. 2004 Jul-Aug;15(4):864-71.

PMID:
15264875
5.

Gastrins, cholecystokinins and gastrointestinal cancer.

Aly A, Shulkes A, Baldwin GS.

Biochim Biophys Acta. 2004 Jul 6;1704(1):1-10. Review.

PMID:
15238241
7.

Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP.

J Nucl Med. 1999 Dec;40(12):2081-7.

8.

Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.

Reubi JC, Schaer JC, Waser B.

Cancer Res. 1997 Apr 1;57(7):1377-86.

9.

Supplemental Content

Support Center